Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Hepatology International|July 24, 2015
Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1Tomoo Miyauchi, Tatsuo Kanda, Fumio Imazeki, et al.
Scientific Reports|July 17, 2023
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patientsTakayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, et al.
Liver Cancer|June 24, 2026
Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular CarcinomaSae Yumita, Sadahisa Ogasawara, Makoto Fujiya, et al.
Investigational New Drugs|September 12, 2017
Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatmentSadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, et al.
Oncology Letters|August 13, 2020
Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancerYushi Imai, Tetsuhiro Chiba, Takayuki Kondo, et al.
Scientific Reports|August 28, 2023
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injuryTakayuki Kondo, Kentaro Fujimoto, Kisako Fujiwara, et al.
Biochemical Pharmacology|February 27, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinomaTakuya Yonemoto, Sadahisa Ogasawara, Naoya Kanogawa, et al.
Scientific Reports|December 1, 2022
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinomaTakayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, et al.
Journal of Gastroenterology|April 7, 2024
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinomaKisako Fujiwara, Takayuki Kondo, Kentaro Fujimoto, et al.
Pageof 16